XTL Biopharmaceuticals Ltd. XTLB

Full chart Compare
Set alert

Price alert · XTLB

All alert types
1.71 USD +0.01 (+0.59%)

At closeNov 5, 2026, 4:00 PM EST

1.52 -0.19 -11.11%

After hours · Nov 5, 4:00 PM ET

1.55 Day range 1.76
1.55 52-week range 5.64
YTD
-26.29%
1 year
-59.29%

Revenue & Expenses

Other Income → Expenses: $331.00KIncome Tax Benefit → Expenses: $31.00KExpenses → Selling, General & Admin: $3.94MExpenses → Research & Development: $11.72MExpenses → Other Operating Expenses: $7.21MExpenses → Interest Expense: $17.00KGross Profit → Expenses: $4.10MRevenue → Gross Profit: $4.10MRevenue → Cost of Revenue: $1.84MNet Loss → Expenses: $18.43MOther Income$331.00KIncome Tax Benefit$31.00KGross Profit$4.10MNet Loss$18.43MCost of Revenue$1.84MExpenses$22.89MSelling, General & Admin$3.94MResearch & Development$11.72MOther Operating Expenses$7.21MInterest Expense$17.00KRevenue$5.94M

Latest period ending Dec 31, 2025 · select a line to chart its full history

XTLB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-1.69M-775.00K-765.00K-880.00K-1.03M
-6.97M-1.03M-1.78M-1.35M435.00K
-3.20-0.80-1.20-0.80—
XTLB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
76.00K371.00K1.40M2.09M2.97M
166.00K8.55M2.43M4.19M6.62M
420.00K3.12M206.00K187.00K1.28M
269.00K138.00K000
-254.00K5.43M2.22M4.00M5.33M
XTLB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-1.02M-1.62M-707.00K-901.00K-1.05M
522.00K-844.00K41.00K36.00K8.00K
208.00K1.45M00385.00K
-295.00K-1.01M-666.00K-865.00K-656.00K